AHZ - Lets go!!!, page-48

I believe all things forecasted have been explicitly stated to not be dependant on... I guess white swan events haha IE things based on a random hopeful great outcome. I believe that we will hit CF+, and if it comes to it will reduce R and d for the tavr in the last quarter ect. But I think majority of the R and D for tavr should be good until the sheep maybe even calf trials are completed. Use that data to drive further. The vaccines imo should never have been started at this stage in the company- imo it was a butterfly effect that’s pushed people away from this stock now. Long term yes, now no but that’s a digression.

I believe that R and D has been pushed to get a prototype and animal trials, and will be backed off now. If it goes well based on what information we have, they won’t be pushing the sales. There will be a partnership or buyout, because this product will be destructive to those facing it in this market and a golden goose for those attached. I believe that WP is going to be smart about this, and would hope he has measures to fight off takeover attempts, staggering the boards and having a lot of options available to current staff are good starts. If these animal trials go well, one way or another, something big will go down, the attentions already on it, the tech is there. This is the iPhone of smartphones if proven, which it’s currrntly being extensively tested. Cheaper to produce, and currently almost 2x longer lasting with no issues once implanted.